Alpha Tau Medical vs MBIA
상장 기업 vs 기존 지방채 보험과 투자에 주력하는 틈새 보험사. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.
Alpha Tau Medical is a development-stage biotech advancing targeted alpha radiation therapy through clinical trials without commercial revenue, while MBIA runs a financial guarantee and insurance business managing legacy structured finance exposures from the 2008 financial crisis. Both companies carry significant uncertainty about future cash flows, but from completely different sources. The Alpha Tau Medical vs MBIA comparison puts clinical pipeline risk alongside legacy liability run-off risk, showing how each company's path to value realization depends on entirely different catalysts and timelines.
Alpha Tau Medical is a development-stage biotech advancing targeted alpha radiation therapy through clinical trials without commercial revenue, while MBIA runs a financial guarantee and insurance busi...
투자 분석
장점
- Alpha Tau Medical is developing a novel cancer therapy with its Alpha-DaRT technology, which is in clinical trials for multiple solid tumour types.
- The company has attracted strong analyst interest, with a consensus 'Strong Buy' rating and a high average price target relative to its current share price.
- Recent financial reports indicate strong growth in the first half of 2025, suggesting improved operational momentum and investor confidence.
고려 사항
- Alpha Tau Medical remains unprofitable, with significant net losses reported over the past year and negative earnings per share.
- The company's revenue is not yet material, reflecting its early-stage clinical development and lack of commercial product sales.
- The stock is highly volatile, with a wide 52-week trading range and a market capitalisation that remains relatively small, increasing risk for investors.
MBIA
MBI
장점
- MBIA maintains a strong position in the municipal bond insurance sector, benefiting from a stable and regulated business model.
- The company has a solid balance sheet with significant liquidity and a history of prudent capital management.
- MBIA's insurance subsidiaries have high financial strength ratings, supporting their ability to underwrite new business and retain clients.
고려 사항
- MBIA's growth is limited by the maturity and slow expansion of the municipal bond insurance market, constraining revenue opportunities.
- The company faces ongoing exposure to legacy liabilities from past financial crises, which could impact future profitability.
- MBIA's stock is sensitive to changes in interest rates and broader credit market conditions, increasing its vulnerability to macroeconomic shifts.
Nemo에서 DRTS 또는 MBI 매수하기
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
현금 예치금 6% 이자
투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.
